Latest News about Drug Enforcement Administration
Recent news which mentions Drug Enforcement Administration
DEA's Case For Scheduling Psychedelics Challenged In Landmark Hearing
November 20, 2024
Tickers
NEWS
From Benzinga
From Benzinga
DEA Faces Lawsuit Alleging Bias In Marijuana Rescheduling Process
November 12, 2024
From Benzinga
DEA Faces Setback As Judge Denies Request To Block Witnesses In Psychedelics Ban Hearing
October 23, 2024
Tickers
NEWS
From Benzinga
DEA Rejects Witnesses For November Hearings On Two Psychedelic Compounds, Advocates Push Back
October 07, 2024
Tickers
NEWS
From Benzinga
DEA Boosts Psychedelics Production For Research, Cannabis Quotas Hold Steady Ahead Of Rescheduling
September 24, 2024
Tickers
NEWS
From Benzinga
DEA Endorses New, Simplified Test To Determine Marijuana's Medical Uses Amid Rescheduling Debate: Could It Also Apply To Psychedelics?
September 17, 2024
Tickers
NEWS
From Benzinga
From Benzinga
DEA Schedules Hearing On Proposed Ban Of Psychedelic Compounds With Therapeutic Potential
August 28, 2024
From Benzinga
Weed Potency Has Increased Dramatically Over Last Several Decades, How High Can THC Limits Go?
May 17, 2024
Tickers
THC
From Benzinga
Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More
April 17, 2024
From Benzinga
VP Kamala Harris Urges DEA To Reschedule Cannabis 'As Quickly As Possible,' Calls Prohibition 'Absurd' & 'Unfair'
March 15, 2024
From Benzinga
Veteran Organizations Urge Biden And DEA To Reform Cannabis Policy, Citing Health Issues
February 22, 2024
Tickers
NEWS
From Benzinga
From Benzinga
DEA Agent Was Fired Over CBD Use, He Sued And Got His Job Back: A Look At A Landmark Case Challenging Cannabis Regulations
January 31, 2024
From Benzinga
DEA Under Pressure To 'Deschedule Marijuana Altogether': 12 US Senators Send Demand To Merrick Garland, Anne Milgram
January 30, 2024
From Benzinga
From Benzinga
The Fate Of Psilocybin's Rescheduling Petition: DEA Retains Control As Federal Court Confirms Case Jurisdiction
December 15, 2023
From Benzinga
DEA Renews Effort To Place 2 Psychedelics In Strictest Drug Category
December 14, 2023
From Benzinga
Should The Biden Administration Reschedule Cannabis By Year-End? Six Governors Say Yes
December 06, 2023
From Benzinga
DEA Acknowledges Psychedelics & Cannabis Research Needs, Seeks Production Increases
November 01, 2023
From Benzinga
DEA Report Shows Reduced Cannabis Testing Amid Legalization
October 03, 2023
From Benzinga
Congressional Research Service Foresees Potential DEA Endorsement Of Marijuana Rescheduling
September 14, 2023
From Benzinga
Cannabis Valuation Jumps Post-Rescheduling Recommendation, Viridian Report Reveals
September 11, 2023
Tickers
TCNNF
From Benzinga
Trulieve CEO: Federal Rescheduling Could Change Heavy Tax Burden For Cannabis Industry
September 06, 2023
From Benzinga
EXCLUSIVE: Curaleaf Chairman Predicts DEA's Future Steps On Cannabis Rescheduling
September 05, 2023
From Benzinga
EXCLUSIVE: How Federal Cannabis Reclassification Could Transform Business Finances, Insights From Cresco Labs' CEO
September 05, 2023
Tickers
CCC
From Benzinga
EXCLUSIVE: End Of Prohibition? Former Senator Cory Gardner Discusses Potential Reclassification Of Cannabis
August 31, 2023
Tickers
CCC
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free
Information
Copyright 2024. BUSINESS INSURANCE HOLDINGS
